Pantoprazole Sodium is the sodium salt form of a substituted benzimidazole with proton pump inhibitor activity. Pantoprazole is a lipophilic, weak base that crosses the parietal cell membrane and enters the acidic parietal cell canaliculus where it becomes protonated, producing the active metabolite sulfenamide, which forms an irreversible covalent bond with two sites of the H+/K+-ATPase enzyme located on the gastric parietal cell, thereby inhibiting both basal and stimulated gastric acid production. It is grouped under the following drug class(es): Proton Pump Inhibitors. Its therapeutic use is listed as gastrointestinal agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Pantecta, Zurcal and Protonix. Its PubChem CID is 15008962.
Pantoprazole sodium
| CAS No | 138786-67-1 |
|---|---|
| Molecular Formula | C16H14F2N3NaO4S |
| Molecular Weight | 405.4 g/mol |
| Synonyms | sodium;5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pantoprazole Sodium is the sodium salt form of a substituted benzimidazole with proton pump inhibitor activity.
The listed CAS number is 138786-67-1.
The listed molecular formula is C16H14F2N3NaO4S.
The listed molecular weight is 405.4 g/mol.
sodium;5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide.
The source lists Pantecta, Zurcal and Protonix.